Jiao Zhang

Beijing, 100083, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2- Advanced Breast Cancer.

Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2- Advanced Breast Cancer.

Journal: Cancer management and research

Published: November 06, 2025

Correction: Real-world outcomes of immune checkpoint inhibitors as second-line therapy for extensive-stage small-cell lung cancer: a multicenter retrospective analysis.

Correction: Real-world outcomes of immune checkpoint inhibitors as second-line therapy for extensive-stage small-cell lung cancer: a multicenter retrospective analysis.

Journal: Frontiers in immunology

Published: September 19, 2025

Immune checkpoint inhibitors continuation beyond progression as second-line treatment for extensive-stage small-cell lung cancer: a real-world, multicenter analysis.

Immune checkpoint inhibitors continuation beyond progression as second-line treatment for extensive-stage small-cell lung cancer: a real-world, multicenter analysis.

Journal: Frontiers in immunology

Published: July 15, 2025

Real-world outcomes of immune checkpoint inhibitors as second-line therapy for extensive-stage small-cell lung cancer: a multicenter retrospective analysis.

Real-world outcomes of immune checkpoint inhibitors as second-line therapy for extensive-stage small-cell lung cancer: a multicenter retrospective analysis.

Journal: Frontiers in immunology

Published: July 02, 2025

Engineering Bacteria as Living Therapeutics in Cancer Therapy.

Engineering Bacteria as Living Therapeutics in Cancer Therapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 29, 2025

COL7A1 indicates crucial potential as a basal membrane-related prognostic biomarker and therapeutic target in lung adenocarcinoma.

COL7A1 indicates crucial potential as a basal membrane-related prognostic biomarker and therapeutic target in lung adenocarcinoma.

Journal: Frontiers in pharmacology

Published: December 11, 2024

Study on roadway layout and surrounding rock control of isolated island panel.

Study on roadway layout and surrounding rock control of isolated island panel.

Journal: Scientific reports

Published: April 11, 2023

Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment.

Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment.

Journal: Theranostics

Published: September 28, 2022

Immune-related genes and gene sets for predicting the response to anti-programmed death 1 therapy in patients with primary or metastatic non-small cell lung cancer.

Immune-related genes and gene sets for predicting the response to anti-programmed death 1 therapy in patients with primary or metastatic non-small cell lung cancer.

Journal: Oncology letters

Published: December 05, 2020

Overexpression of abnormal spindle-like microcephaly-associated (ASPM) increases tumor aggressiveness and predicts poor outcome in patients with lung adenocarcinoma.

Overexpression of abnormal spindle-like microcephaly-associated (ASPM) increases tumor aggressiveness and predicts poor outcome in patients with lung adenocarcinoma.

Journal: Translational cancer research

Published: July 22, 2020

EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma.

EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma.

Journal: Aging

Published: June 10, 2020

Gene Expression-Based Immune Cell Infiltration Analyses of Prostate Cancer and Their Associations with Survival Outcome.

Gene Expression-Based Immune Cell Infiltration Analyses of Prostate Cancer and Their Associations with Survival Outcome.

Journal: DNA and cell biology

Published: May 29, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026